Live
- JAIN International Residential School, Bengaluru jointly with The Sports School to announce India’s First Integrated Scholarship Future25
- Sale certificate issued in pursuance to a court's auction not required to be stamped: Supreme Court
- Andhra Pradesh: Jagan flays Chandrababu-led govt for neglect of education
- Sri Lanka issues flood warnings for 12 flood-prone river basin areas
- IPL 2025 Auction: Venkatesh Iyer sold to KKR for Rs 23.75 cr, Stoinis joins PBKS for Rs 11 crore
- Kharge to lead Opposition strategy meeting as Parliament session kicks off on Monday
- Three killed in firing as violence breaks out amid Sambhal mosque survey in UP
- IPL 2025 Auction: Ravichandran Ashwin, Rachin Ravindra return to Chennai Super Kings
- Manipur: After over a week's closure, regular classes to resume in educational institutions
- Govt open to discuss all issues, says Kiren Rijiju on eve of Winter Session of Parliament
Sanofi India Q4FY22 Results: Consolidated profit rises 63% YoY to Rs 238 crore
Sanofi India Q4FY22 Results: Consolidated profit rises 63% YoY to Rs 238 crore
Sanofi India on Tuesday reported a 63% YoY rise in the consolidated profit at Rs 238 crore for the quarter ended March 31, 2022.
Sanofi India on Tuesday reported a 63% YoY rise in the consolidated profit at Rs 238 crore for the quarter ended March 31, 2022. The pharmaceutical company had posted a profit of Rs 146 crore in the corresponding quarter of the last financial year. The company has also reported an exceptional gain of Rs 118 crore in the March 2022 quarter.
The company's revenue from operations fell 2.5% YoY to Rs 707 crore as compared to Rs 725 crore posted in the March 2021 quarter. It posted an EBITDA of Rs 194.5 crore, which is 3% higher YoY compared to Rs 188.8 crore posted last year.
The company's margin improved to 27.5% in the reported quarter against 26% posted last year.
Sanofi India is one of the entities through which Sanofi operates in India. The company that has been present in India since 1956 is known as a household brand in pain and allergy. It offers a wide array of medicines for therapeutic areas such as diabetes, cardiology, thrombosis, central nervous system and antihistamines. The products manufactured by the company are distributed in India and exported to many developed as well as developing countries.
